Trial intelligence / Profile preview

Methylene Blue for Neuropathic Pain

NCT02303886Completed

Sponsor
Uppsala University
Start
Mar 2009
Primary completion
Jun 2012
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of methylene blue in neuropathic pain (2 arms), sponsored by Uppsala University. Primary endpoint: Pain Visual Analogue Scale (VAS) at 5 days. Started Mar 2009; status: completed.

02

Drugs

methylene blue
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT02303886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02303886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call